Mitsubishi Ufj Trust & Banking Corp Alnylam Pharmaceuticals, Inc. Transaction History

Mitsubishi Ufj Trust & Banking Corp

  • $43.4 Billion
  • Q3 2024

A detailed history of Mitsubishi Ufj Trust & Banking Corp transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Mitsubishi Ufj Trust & Banking Corp holds 120,332 shares of ALNY stock, worth $29.2 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
120,332
Previous 268,440 55.17%
Holding current value
$29.2 Million
Previous $65.2 Million 49.26%
% of portfolio
0.08%
Previous 0.16%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$233.81 - $287.01 $34.6 Million - $42.5 Million
-148,108 Reduced 55.17%
120,332 $33.1 Million
Q2 2024

Aug 08, 2024
SELL
$143.31 - $247.0 $6.22 Million - $10.7 Million
-43,412 Reduced 13.92%
268,440 $65.2 Million
Q1 2024

May 10, 2024
SELL
$146.51 - $198.2 $5.46 Million - $7.39 Million
-37,268 Reduced 10.67%
311,852 $46.6 Million
Q4 2023

Feb 09, 2024
SELL
$151.41 - $196.57 $5.69 Million - $7.38 Million
-37,552 Reduced 9.71%
349,120 $66.8 Million
Q3 2023

Nov 09, 2023
SELL
$170.77 - $211.65 $1.16 Million - $1.43 Million
-6,769 Reduced 1.72%
386,672 $68.5 Million
Q2 2023

Aug 08, 2023
SELL
$185.01 - $212.05 $2.68 Million - $3.07 Million
-14,493 Reduced 3.55%
393,441 $74.7 Million
Q1 2023

May 10, 2023
SELL
$182.66 - $235.53 $9.54 Million - $12.3 Million
-52,241 Reduced 11.35%
407,934 $81.7 Million
Q4 2022

Feb 10, 2023
SELL
$185.53 - $241.31 $2.69 Million - $3.49 Million
-14,473 Reduced 3.05%
460,175 $109 Million
Q3 2022

Nov 10, 2022
BUY
$138.54 - $232.0 $79,244 - $132,704
572 Added 0.12%
474,648 $95 Million
Q2 2022

Aug 09, 2022
BUY
$120.42 - $169.29 $677,242 - $952,086
5,624 Added 1.2%
474,076 $69.1 Million
Q1 2022

May 12, 2022
SELL
$127.18 - $173.91 $325,453 - $445,035
-2,559 Reduced 0.54%
468,452 $76.5 Million
Q4 2021

Feb 09, 2022
SELL
$159.56 - $209.29 $2.53 Million - $3.31 Million
-15,837 Reduced 3.25%
471,011 $79.9 Million
Q3 2021

Nov 12, 2021
SELL
$169.75 - $207.73 $2.01 Million - $2.45 Million
-11,814 Reduced 2.37%
486,848 $91.9 Million
Q2 2021

Aug 12, 2021
SELL
$128.63 - $176.89 $3.01 Million - $4.14 Million
-23,429 Reduced 4.49%
498,662 $84.5 Million
Q1 2021

May 12, 2021
SELL
$126.83 - $175.69 $2.63 Million - $3.65 Million
-20,751 Reduced 3.82%
522,091 $73.7 Million
Q4 2020

Feb 12, 2021
SELL
$122.97 - $147.0 $1.29 Million - $1.54 Million
-10,507 Reduced 1.9%
542,842 $70.6 Million
Q3 2020

Nov 12, 2020
SELL
$121.19 - $165.49 $1.97 Million - $2.69 Million
-16,265 Reduced 2.86%
553,349 $80.6 Million
Q2 2020

Sep 11, 2020
SELL
$104.21 - $156.44 $82.6 Million - $124 Million
-792,544 Reduced 58.18%
569,614 $84.4 Million
Q2 2020

Aug 13, 2020
BUY
$104.21 - $156.44 $81.7 Million - $123 Million
783,732 Added 135.49%
1,362,158 $84.4 Million
Q1 2020

May 13, 2020
BUY
$93.12 - $133.99 $4.65 Million - $6.7 Million
49,981 Added 9.46%
578,426 $63 Million
Q4 2019

Feb 14, 2020
BUY
$74.51 - $124.23 $481,781 - $803,271
6,466 Added 1.24%
528,445 $60.9 Million
Q3 2019

Nov 12, 2019
BUY
$70.9 - $87.82 $9.02 Million - $11.2 Million
127,281 Added 32.25%
521,979 $42 Million
Q2 2019

Aug 07, 2019
BUY
$65.86 - $92.79 $228,995 - $322,630
3,477 Added 0.89%
394,698 $28.6 Million
Q1 2019

May 13, 2019
BUY
$72.76 - $93.45 $3.37 Million - $4.32 Million
46,252 Added 13.41%
391,221 $36.6 Million
Q4 2018

Feb 12, 2019
SELL
$62.67 - $88.33 $1.51 Million - $2.12 Million
-24,035 Reduced 6.51%
344,969 $25.2 Million
Q3 2018

Nov 13, 2018
SELL
$87.52 - $122.67 $10 Million - $14 Million
-114,347 Reduced 23.66%
369,004 $32.3 Million
Q2 2018

Aug 10, 2018
SELL
$88.31 - $107.8 $684,402 - $835,450
-7,750 Reduced 1.58%
483,351 $47.6 Million
Q1 2018

May 11, 2018
BUY
$115.92 - $148.54 $4.8 Million - $6.16 Million
41,446 Added 9.22%
491,101 $58.5 Million
Q4 2017

Feb 09, 2018
BUY
$114.49 - $139.98 $19.6 Million - $24 Million
171,308 Added 61.54%
449,655 $57.1 Million
Q3 2017

Nov 13, 2017
BUY
$72.53 - $118.27 $20.2 Million - $32.9 Million
278,347
278,347 $32.7 Million

Others Institutions Holding ALNY

# of Institutions
643
Shares Held
109M
Call Options Held
1.28M
Put Options Held
1.21M
View Full List

About ALNYLAM PHARMACEUTICALS, INC.

ALNY Quotes by TradingView
  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $29.8B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Mitsubishi Ufj Trust & Banking Corp Portfolio

Follow Mitsubishi Ufj Trust & Banking Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Trust & Banking Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Trust & Banking Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email